The investigation of blood concentrations of beta-cryptoxanthin associated with long term ingestion of Ripe Kumquats "Tama-Tama". : A randomization open-label, non-eating simultaneous control comparison group study - The clinical trial for blood concentrations of beta-cryptoxanthin associated with long term ingestion of Ripe Kumquats "Tama-Tama"

niversity of Miyazaki0 个研究点目标入组 12 人开始时间: 2017年9月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who have respiratory, gastrointestinal, hepatic/gallbladder/pancreatic, hematologic, renal, endocrine, cardiovascular and/or mental disease, or who have history of those diseases. 2. Subjects who have a serious injury or surgical history within 12 weeks prior to this study. 3. Pre- or post-menopausal women having obvious changes in physical condition. 4. Subjects who are at risk of having allergic reaction to citrus foods including kumquat. 5. Subjects who have history of allergic reaction to foods or drugs which needs its treatment or who have possibility of the reaction. 6. Subjects who are heavy smoker (more than 21 cigarettes per day), or alcohol addicts (more than 20g per day alcohol), or alcohol or drug dependency or who have possibility of the dependency. 7. Subjects who regularly take drugs, foods for specified health uses, foods with function claims and/or supplements, etc. which would affect this study. 8. Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within four weeks or blood components within two weeks prior to this study. 9. Pregnant or lactating women or women expect to be pregnant during this study. 10. Subjects who have cognitive disorder or who have possibility of the disorder. 11. Subjects who participate and take the study drug in other clinical trials within 12 weeks prior to this study. 12. Subjects who are judged as unsuitable for this study by the principal investigator or subinvestigators.

发起方

niversity of Miyazaki